Levine Zurit sold $5K of CGEN
Levine Zurit (SVP, Business Development) sold 1,875 shares of COMPUGEN LTD (CGEN) at $2.50 on 2026-07-09 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The only new fact is the officer’s planned open-market sale details; it does not include new operational, financial, or regulatory information about CGEN.
Market read
Traders may note the insider sale for sentiment monitoring, but it is unlikely to drive a fundamental repricing.
What to watch
The sale size ($4,687.50) is small relative to typical market moves, and the 10b5-1 structure reduces interpretability as a new negative signal.
Background
The article is an SEC Form 4 insider transaction disclosure for Compugen Ltd (CGEN).
Ticker impact
SEC Form 4 shows CGEN SVP Levine Zurit sold 1,875 shares at $2.50 on 2026-07-09 under a 10b5-1 plan.
Likely minimal impact on CGEN price; any effect is more about liquidity/positioning than new company information.
The filing discloses a small, pre-planned sale by an officer, without any accompanying guidance, deal, or regulatory/operational change.
Market effects
No clear sector read-through from a single planned insider sale.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can coincide with investor caution, so traders may still watch for follow-on selling patterns.
Key entities
- issuerCompugen Ltd
Subject of the Form 4 insider transaction disclosure.
- insiderLevine Zurit
SVP, Business Development who executed the sale under a 10b5-1 plan.